Key result
Cardiac markers such as troponin provide high cardiac specificity and low detection limits, enabling the detection of minor myocardial infarction and identifying patients at high risk for death and AMI.
Answers are grounded in this paper and cite their sources.
The evolution of cardiac biomarkers has culminated in the use of troponin, which offers high specificity and sensitivity for diagnosing minor myocardial infarction and predicting adverse outcomes in unstable angina.
It was recognized very early that the specificity of AST, LDH, and CK was not high for cardiac diseases, as injury to the liver and skeletal muscles and hemolysis produced falsely positive results. Thus the measurement of isoenzymes becomes important to improve the specificity of total enzyme measurements. Assays for CK and LD isoenzymes were initially developed using electrophoresis. Because this assay was time consuming and difficult to automate, imunooinhibition assays were soon developed. The development of immunoassay measurements enabled determination of the enzyme concentration which was not dependent on whether or not the enzyme was active. These "mass assays" also enabled the measurement of protein markers which are themselves not enzymes. This led to the investigation of many other markers for potential use in cardiac diseases. With changing clinical practices, cardiac markers are now needed to detect the presence of minor myocardial infarction in patients with unstable angina. Outcome studies have shown that patients with increased troponin are at high short-term risk for death and AMI. The success of new cardiac markers such as troponin is due to their high cardiac specificity and the existence of assays with low detection limits.
No takes yet. Share an insight, caveat, or question.
Nada Majkić‐Singh (2003) conducted a review in Acute coronary syndromes. Biochemical markers (e.g., troponin) was evaluated. Cardiac markers such as troponin provide high cardiac specificity and low detection limits, enabling the detection of minor myocardial infarction and identifying patients at high risk for death and AMI.
Synapse has enriched 10 related papers. Consider them for comparative context: